Antiparasitic Drugs Market is growing rapidly with Bajaj Healthcare introducing Ivejaj, an antiparasitic drug, for the treatment of COVID-19
Antiparasitic drugs are a category of medicines that are mainly indicated for the cure of allergic parasitic infections, like those caused by the amoeba, helminth, parasitic protozoans, and other fungi, among many others. Medicine in this category is called antifungal and it contains active ingredients capable of preventing the growth of such microorganisms. Many drug manufacturers are focused on launching generic drug products, so as to expand their market presence. A generic drug contains the same chemical substance as a drug that was original protected by chemical patients. These drugs are allowed to sell after the patents on the original drugs expire. Since there is an increasing launch of generic drugs, the antiparasitic drugs market could expand in the near future. Recently, in May 2021, Bajaj Healthcare launched Ivejaj, an antiparasitic drug, for the treatment of COVID-19. Since the prevalence of parasitic diseases such as Chagas disease has increased, the demand for ant...